sk&f-38393 has been researched along with naxagolide in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (11.11) | 18.7374 |
1990's | 8 (88.89) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Martin-Iverson, MT; Yamada, N | 2 |
Martin-Iverson, MT | 1 |
Chiodo, LA; Freeman, AS; Kelland, MD; LeWitt, PA | 1 |
Boyce, S; Iversen, SD; Rupniak, NM; Steventon, MJ | 1 |
Iversen, SD; Martin-Iverson, MT; Stahl, SM | 1 |
Edwards, MA; Kantak, KM; Spealman, RD | 1 |
Bergman, J; Rosenzweig-Lipson, S; Spealman, RD | 1 |
Bergman, J; Tidey, JW | 1 |
9 other study(ies) available for sk&f-38393 and naxagolide
Article | Year |
---|---|
Synergistic behavioural effects of dopamine D1 and D2 receptor agonists are determined by circadian rhythms.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Behavior, Animal; Circadian Rhythm; Darkness; Dopamine Agents; Drug Synergism; Drug Tolerance; Light; Locomotion; Male; Motor Activity; Oxazines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Time Factors | 1992 |
Chronic treatment with D1 and D2 dopamine receptor agonists: combined treatments interact to differentially affect brain levels of monoamines.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Biogenic Monoamines; Brain; Dopamine; Dopamine Agents; Drug Interactions; Drug Therapy, Combination; Homovanillic Acid; Male; Norepinephrine; Oxazines; Rats; Rats, Inbred Strains; Time Factors | 1991 |
Selective dopamine D1 and D2 agonists independently affect different components of the free-running circadian rhythm of locomotor activity in rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Circadian Rhythm; Light; Male; Motor Activity; Oxazines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2 | 1991 |
Effects of (+)-4-propyl-9-hydroxynaphthoxazine on midbrain dopamine neurons: an electrophysiological study.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; 5,7-Dihydroxytryptamine; Animals; Antiparkinson Agents; Corpus Striatum; Dopamine Agents; Ergolines; Iontophoresis; Male; Nucleus Accumbens; Oxazines; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2 | 1990 |
Differential effects of D1 and D2 agonists in MPTP-treated primates: functional implications for Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Behavior, Animal; Benzazepines; Dyskinesia, Drug-Induced; Levodopa; Male; Motor Activity; Oxazines; Parkinson Disease, Secondary; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Saimiri | 1990 |
Long-term motor stimulant effects of (+)-4-propyl-9-hydroxynaphthoxazine (PHNO), a dopamine D-2 receptor agonist: interactions with a dopamine D-1 receptor antagonist and agonist.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antipsychotic Agents; Appetite Depressants; Benzazepines; Dopamine Agents; Dopamine Antagonists; Drug Tolerance; Injections, Subcutaneous; Male; Motor Activity; Oxazines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Stress, Physiological | 1988 |
Effects of N-methyl-D-aspartate antagonists in rats discriminating different doses of cocaine: comparison with direct and indirect dopamine agonists.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Cocaine; Discrimination Learning; Dopamine Agonists; Male; N-Methylaspartate; Oxazines; Piperazines; Rats; Rats, Wistar | 1995 |
Differential effects of dopamine D1 and D2 receptor agonists on schedule-controlled behavior of squirrel monkeys.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Conditioning, Psychological; Dopamine Agonists; Indoles; Male; Oxazines; Phenanthridines; Phenethylamines; Receptors, Dopamine D1; Receptors, Dopamine D2; Saimiri | 1995 |
Drug discrimination in methamphetamine-trained monkeys: agonist and antagonist effects of dopaminergic drugs.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adrenergic Agents; Animals; Benzazepines; Catalepsy; Discrimination Learning; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Ergolines; Male; Methamphetamine; Oxazines; Receptors, Dopamine D1; Receptors, Dopamine D2; Saimiri | 1998 |